News
SIGN UP FOR OUR FREE NEWSLETTER
NEWS IN BRIEF

Wilson Therapeutics confirms positive Phase II data for WTX101

Advent France Biotechnology launches €64.75 seed-fund

Curetis lauches new Univero product in Europe

SEE ALL
PRODUCT OF THE WEEK

The SIDUS® technology platform

The SIDUS® platform covers Retroviral vectors (i.e. Lentiviral), Adeno-associated viral vectors (AAV), Measles vectors, Adenoviral vectors and Pox...

THE MAG

Are health apps set to revolutionise the insurance industry? European major Generali believes they are, and is rolling out a programme to reward...

PEOPLE
Up To Date
CONTACT US

BIOCOM AG

Luetzowstraße 33-36
10785 Berlin, Germany

P +49-30-264921-0
F +49-30-264921-11

service(at)biocom.de

POLL OF THE MONTH

Should crops altered by genome editing techniques such as CRISPR/Cas9 be classified as GMOs?

25%
Yes
75%
No
WEEKLY POLL

Should crops altered by genome editing techniques such as CRISPR/Cas9 be classified as GMOs?

Events
FEATURED EVENT

BioProcess International European Summit

25.-26.04.2017 in RAI, Amsterdam, NL

THE Bioprocessing event, bringing together 800+ attendees from all major departments in bioprocessing: Cell Culture, Downstream, Manufacturing, Vaccines, Viral Safety and Cell Line Development.

MORE

FEATURED EVENT

Swiss Biotech Day 2017

04.05.2017 in Basel, Switzerland

The Swiss Biotech Day has long become the standard annual get-together of the Swiss bio­pharmaceutical industry. So mark your calendar for next year’s event in May 2017 in Basel. 

MORE

UPCOMING EVENTS

7th European Algae Industry Summit

26.04. - 27.04.2017
ǀ Nice (F)

Molecular Chaperones in Cancer

02.05. - 04.05.2017
ǀ Madrid (ES)

Swiss Biotech Day 2017

04.05.2017
ǀ Basel (CH)

BioTrinity 2017

08.05. - 10.05.2017
ǀ London (UK)
SEE ALL